PRA Health Sciences (PRA) is dedicated to ensuring quality Aggregate Safety Reports are delivered to our sponsor and MAH partners. Our experienced team of talented Pharmacovigilance professionals offer clear, comprehensive, and effective processes for successful development of Aggregate Safety Reports. Through our use of innovative technologies, the provision of safety data is automated and team review of the Aggregate Safety Reports can be electronically tracked, thereby providing a more streamlined approach to report generation and management.
PV Nugget #7 Pharmacogenomics
Pharmacogenomics (PGx) focuses on how genes and biomarkers can affect how an individual respond to drugs. The goal of PGx is to develop effective,…
Pharmacovigilance & Patient Safety
Clinical trial participants help us speed breakthroughs in modern drug development. Our job is to protect them.
PV Nugget #6 Literature Surveillance
Literature is regarded as a significant source of information in the monitoring of a medicinal product, its safety profile, and benefit-risk balance.…